查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030215

血液輸注設備市場－全球產業規模、佔有率、趨勢、機會與預測：按產品、最終用途、地區和競爭格局分類，2021-2031年

Blood Transfusion Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球輸血醫療設備市場預計將從 2025 年的 49.7 億美元成長到 2031 年的 69.7 億美元，複合年成長率為 5.8%。

這些專用醫療設備，包括輸血導管、輸液管和過濾器，旨在確保血液及其成分從捐血者安全、合理地靜脈注射至病患。市場成長主要受全球創傷、手術和慢性疾病輸血需求不斷成長的驅動。此外，腎臟病、癌症和貧血等需要反覆輸血的疾病發生率上升，也對該行業的發展起到了重要作用。特別是，AABB 2025年年會摘要指出，預計2024年各醫療機構輸注的紅血球濃縮液總量將比2019年的11,850單位下降約15-23%（以基線以金額為準）。

市場概覽
預測期 2027-2031
市場規模：2025年 49.7億美元
市場規模：2031年 69.7億美元
複合年成長率：2026-2031年 5.8%
成長最快的細分市場 血液分離系統
最大的市場 北美洲

阻礙該市場成長的主要障礙是先進輸血技術相關的高昂營運成本和資本投資。這些巨額成本構成了採用這些設備的經濟壁壘，尤其是在中低收入國家，從而限制了全球獲得最先進輸血療法的機會。

市場促進因素

血液輸注設備需求的主要促進因素是手術數量的增加。許多複雜且耗時的醫療手術都需要輸血來控制出血並穩定病患病情。在全球範圍內，由於外科技術的進步和醫療服務覆蓋範圍的擴大，手術數量正在穩步成長。一項發表於2025年11月PMC會議的系統性綜述支持了這一趨勢，該綜述預測，到2050年，全髖置換術術（THA）的數量將激增121%至200%以上，全膝關節置換術術（TKA）的數量將在全球範圍內至少凸成長130%，這顯了需要定期輸血的持續治療方式。

此外，慢性病和血液疾病發生率的激增是推動輸血醫療設備產業擴張的主要動力。鐮狀細胞貧血、重度貧血、地中海貧血以及某些類型的癌症等疾病通常需要定期或常規輸血才能有效患者照護。這些健康問題的全球影響巨大，世界衛生組織（世衛組織）發布的《2025年貧血報告》顯示，2023年15至49歲女性中，30.7%患有貧血。持續的血液需求直接加速了對高效能輸血設備的需求。同時，美國紅十字會在2026年1月報告稱，全國血液供應量較上月下降了35%，凸顯了輸血用​​血供應面臨的嚴峻挑戰。

市場挑戰

先進輸血技術所需的巨額資本投資和營運成本是限制全球輸血設備市場擴張的主要障礙。這些高昂的成本對醫療機構構成經濟負擔，顯著降低了中低收入國家的採用率。安裝先進設備所需的高額初始成本，加上持續的維護和營運費用，嚴重限制了許多醫療機構購買或升級最新輸血系統的能力。

這些經濟壓力正透過限制買家的財務柔軟性和延緩新技術的應用，直接減緩市場成長。根據美國血庫協會 (AABB) 2025 年會摘要，一個案例凸顯了這個問題：某醫院系統在血液製品上的總支出激增 19.8%，從 2020 年的 1280 萬美元增至 2024 年的 1530 萬美元。血液製品採購相關營運成本的上升將進一步擠佔用於投資尖端輸血設備的資金，最終阻礙市場擴張和先進醫療保健系統的全球部署。

市場趨勢

血液採集和血液製品處理設備的自動化程度不斷提高，已成為產業發展的重要趨勢，有助於提高生產效率並減少血液製品製備過程中的人為錯誤。這一轉變對該領域產生了重大影響，催生了對先進自動化技術的需求，這些技術能夠最佳化檢查室操作並提高檢體管理的準確性。 AABB 2025 年會的一篇摘要詳細闡述了這一優勢，該摘要介紹了一家領先的學術研究型醫院如何利用自動化免疫血液分析儀，將技術人員在每個紅血球抗原檢測週期中節省約兩小時的時間。對於需要快速可靠地處理日益成長的血液製品量的輸血中心和血庫而言，這種效率的提升至關重要。

同時，即時檢測（POC​​）和家用輸血設備的日益普及凸顯了醫療保健領域的一項重大進步，使得患者無需再完全依賴傳統醫療機構，即可在自身環境中直接輸血。這一趨勢拓展了輸血療法的應用範圍，尤其惠及那些需要快速或定期輸血的患者。因此，業界對操作簡單、便攜且能在各種非醫院環境下安全高效地輸注血液成分的設備需求激增。為了支持這一轉變，美國血液中心於2026年2月發布了最新的院前輸血全國統計數據，證實這些關鍵操作通常在患者到達醫療機構之前進行，凸顯了輸血設備在居家照護和急救中日益重要的作用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球輸血設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類別（血液分離系統、輸液裝置、血液加溫器、靜脈通路裝置、過濾器、其他）
    • 依用途（醫院、門診手術中心、透析中心、血庫、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美輸血設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲輸血設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區輸血設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲輸血設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲輸血設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球輸血設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Immucor Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Grifols SA
  • Kaneka Corporation
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • Macopharma SA
  • Ecomed Solutions, LLC.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 5061

The Global Blood Transfusion Devices Market is projected to grow from USD 4.97 Billion in 2025 to USD 6.97 Billion by 2031 at a 5.8% CAGR. These specialized medical tools, which include access catheters, tubing, and filters, are engineered to enable the secure and regulated intravenous delivery of blood and its components from donors to patients. Market growth is largely fueled by the rising worldwide frequency of trauma incidents, surgeries, and chronic illnesses that rely on transfusions. Additionally, the growing rates of health issues requiring repeated blood transfusions, like kidney disease, cancer, and anemia, play a major role in driving the industry forward. Notably, an abstract from the AABB 2025 Annual Meeting highlighted that overall institutional transfusions of packed red blood cells in 2024 maintained a decrease of roughly 15-23% against the 2019 baseline of 11,850 units.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.97 Billion
Market Size 2031USD 6.97 Billion
CAGR 2026-20315.8%
Fastest Growing SegmentApheresis Systems
Largest MarketNorth America

A major hurdle hindering the growth of this market is the high operational and capital expenditure tied to sophisticated transfusion technologies. Such hefty costs often act as a financial obstacle to the implementation of these devices, especially in low- and middle-income nations, consequently restricting global access to state-of-the-art transfusion treatments.

Market Driver

A major factor propelling the need for blood transfusion equipment is the rising number of surgical operations, given that many lengthy and complex medical interventions depend on transfusions to control bleeding and keep patients stable. Improved surgical methods and broader healthcare accessibility have led to a consistent global increase in the number of surgeries performed. Highlighting this trend, a November 2025 systematic review in PMC projected that by 2050, Total Hip Arthroplasty (THA) procedures could surge by 121% to over 200%, while Total Knee Arthroplasty (TKA) operations are anticipated to grow by a minimum of 130% internationally, emphasizing the ongoing expansion of treatments that regularly require blood support.

Additionally, the escalating rates of chronic illnesses and blood disorders serve as a core catalyst for the expansion of the blood transfusion devices industry. Illnesses like sickle cell disease, severe anemia, thalassemias, and specific types of cancer often depend on periodic or routine blood transfusions for effective patient care. The Global footprint of these health issues is immense, with the World Health Organization's 2025 anemia report indicating that 30.7% of women between 15 and 49 years old experienced anemia in 2023. This ongoing requirement for blood directly accelerates the need for highly effective transfusion tools, even as the American Red Cross reported a 35% drop in the national blood supply in January 2026 compared to the previous month, underscoring severe constraints on the availability of transfusable blood.

Market Challenge

The heavy financial burden regarding both capital and operational expenses for cutting-edge transfusion technologies poses a major obstacle to the expansion of the Global Blood Transfusion Devices Market. These steep costs create fiscal roadblocks for medical facilities, disproportionately lowering adoption rates in low- and middle-income nations. The steep upfront costs needed to procure advanced machinery, combined with continuous maintenance and running fees, severely restrict the capacity of numerous healthcare institutions to purchase or upgrade to contemporary transfusion systems.

Such economic pressures directly slow down market growth by limiting buyers' financial flexibility and postponing the adoption of new technologies. Highlighting this issue, an abstract from the AABB 2025 Annual Meeting revealed that a hospital system's overall expenditure on blood products surged by 19.8%, climbing from $12.8 million in 2020 to $15.3 million in 2024. The escalating operational costs associated with acquiring blood products subsequently shrink the funds available for investing in updated blood transfusion equipment, ultimately hindering market reach and the global deployment of advanced medical systems.

Market Trends

The rising integration of automation within blood collection and processing equipment is a central industry trend, serving to boost productivity and reduce human error during blood product preparation. This shift significantly impacts the sector by generating demand for sophisticated, automated technologies that optimize laboratory operations and increase the precision of sample management. Demonstrating this benefit, an abstract from the AABB 2025 Annual Meeting detailed how a major academic and research hospital saved roughly two hours of a technologist's time per cycle during red blood cell antigen testing by utilizing an automated immunohematology analyzer. These improvements in efficiency are essential for transfusion centers and blood banks needing to process growing quantities of blood products rapidly and reliably.

At the same time, the rising adoption of point-of-care and home-based transfusion equipment highlights a major evolution in medical care, bringing blood administration directly into the patient's immediate environment rather than relying solely on conventional clinical facilities. This movement broadens the reach of transfusion treatments, especially for individuals who need rapid or recurring care. As a result, the industry is seeing a surge in requests for intuitive, portable instruments that can securely and efficiently deliver blood components across various non-hospital environments. Supporting this shift, America's Blood Centers reported in February 2026 that new national statistics on prehospital transfusions confirm these critical interventions are frequently taking place before patients arrive at medical centers, underscoring the expanding role of transfusion equipment in home care and emergency situations.

Key Market Players

  • Immucor Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Grifols SA
  • Kaneka Corporation
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • Macopharma SA
  • Ecomed Solutions, LLC.

Report Scope

In this report, the Global Blood Transfusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Transfusion Devices Market, By Product

  • Apheresis Systems
  • Infusion Devices
  • Blood Warmers
  • Venous Access Devices
  • Filters
  • Others

Blood Transfusion Devices Market, By End Use

  • Hospital
  • Ambulatory Surgical Centers
  • Dialysis Centers
  • Blood Bank
  • Others

Blood Transfusion Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Transfusion Devices Market.

Available Customizations:

Global Blood Transfusion Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Transfusion Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
    • 5.2.2. By End Use (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Blood Transfusion Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Transfusion Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Blood Transfusion Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Blood Transfusion Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End Use

7. Europe Blood Transfusion Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Transfusion Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Blood Transfusion Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Blood Transfusion Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Blood Transfusion Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Blood Transfusion Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End Use

8. Asia Pacific Blood Transfusion Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Transfusion Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Blood Transfusion Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Blood Transfusion Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Blood Transfusion Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Blood Transfusion Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Blood Transfusion Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Blood Transfusion Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Blood Transfusion Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Blood Transfusion Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End Use

10. South America Blood Transfusion Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Transfusion Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Blood Transfusion Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Blood Transfusion Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood Transfusion Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Immucor Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Becton Dickinson and Company
  • 15.3. B. Braun Melsungen AG
  • 15.4. Terumo Corporation
  • 15.5. Grifols SA
  • 15.6. Kaneka Corporation
  • 15.7. Fresenius Kabi AG
  • 15.8. Haemonetics Corporation
  • 15.9. Macopharma SA
  • 15.10. Ecomed Solutions, LLC.

16. Strategic Recommendations

17. About Us & Disclaimer